Ammonium formate → (S)-4-(methyl(piperidin-3-yl)amino)-5,6-dihydropyrido[2,3-d]pyrimidin-7(8H)-one
Reaction equation
C([N:8]1[CH2:13][CH2:12][CH2:11][C@H:10]([N:14]([CH3:26])[C:15]2[C:16]3[CH2:24][CH2:23][C:22](=[O:25])[NH:21][C:17]=3[N:18]=[CH:19][N:20]=2)[CH2:9]1)C1C=CC=CC=1.C([O-])=O.[NH4+]>CO.[Pd]>[CH3:26][N:14]([C@H:10]1[CH2:11][CH2:12][CH2:13][NH:8][CH2:9]1)[C:15]1[C:16]2[CH2:24][CH2:23][C:22](=[O:25])[NH:21][C:17]=2[N:18]=[CH:19][N:20]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of (S)-4((1-benzylpiperidin-3-yl)(methyl)amino)-5,6-dihydropyrido[2,3-d]pyrimidin-7(8H)-one (100 mg, 0.3 mmol) in MeOH (3 mL) was added 10% Pd/C (100 mg) and ammonium formate (179 mg, 2.8 mmol) and the reaction mixture was heated for overnight. The reaction mixture was filtered and concentrated in vacuo to afford (72 mg, 96%) of the titled intermediate which was used without purification. LC-MS: m/z [M+1]=262.
Workup
- temperaturethe reaction mixture was heated for overnight
- filtrationThe reaction mixture was filtered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-ed08e91d5bef4c609303c6a5de0aff94
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09273028B2
Reaction notes
Loading…